Women’s Health Lecture Series: Addressing social determinants of health
The National Institutes of Health (NIH) will host a virtual panel discussion on Wednesday, July 22, 2020 from 2 p.m. to 3 p.m. EST.
The latest installment of the Understudied, Underrepresented, Underreported (U3) Women’s Health Lecture Series of the NIH Office of Research on Women’s Health (ORWH) will feature presentations from Dr. Marie Lynn Miranda, of the University of Notre Dame, and Dr. Leah H. Rubin, of John Hopkins University.
The webinar, titled “Improving Chronic Disease Outcomes Through Approaches that Address Social Determinants of Health,” will take place on Zoom. The presenters will discuss a range of important topics, including racial disparities in relation to health and education, patterns of racial segregation throughout the United States, and how using new technology in routine HIV clinical care could improve patient outcomes.
The purpose of the U3 Women’s Health Lecture Series is to drive interest toward the complex issues affecting women’s health.
Register here or visit the event page to learn more.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
